Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transitional Cell Carcinoma of Urinary Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03159143
What this trial is testing

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Urothelial Tract
Leonard Appleman 22
Large-scale testing (Phase 3)Study completedNCT02632409
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 709
Testing effectiveness (Phase 2)UnknownNCT00005958
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Amgen
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Not applicableLooking for participantsNCT06169436
What this trial is testing

Translational Cancer Observational Protocol

Who this might be right for
Upper Urinary Tract Urothelial Carcinoma
IRCCS San Raffaele 1,250
Not applicableStudy completedNCT04535921
What this trial is testing

Fear of Cancer Recurrence in Genitourinary Cancer

Who this might be right for
Fear of Cancer RecurrenceProstate CancerRenal Cell Cancer+2 more
Ludwig-Maximilians - University of Munich 500
Testing effectiveness (Phase 2)Study completedNCT02109328
What this trial is testing

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Who this might be right for
Bladder CancerTransitional Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Early research (Phase 1)Looking for participantsNCT05614739
What this trial is testing

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company 677
Testing effectiveness (Phase 2)Study completedNCT00028860
What this trial is testing

Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Tulane University Health Sciences Center
Post-approval studies (Phase 4)Study completedNCT04197089
What this trial is testing

Biological Effect of Vitamin D in Patients With Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Germans Trias i Pujol Hospital 2
Not applicableLooking for participantsNCT05731622
What this trial is testing

Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC

Who this might be right for
Upper Urinary Tract Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 100
Early research (Phase 1)Ended earlyNCT00565227
What this trial is testing

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Who this might be right for
Non-Small-Cell Lung CarcinomaProstate CancerBladder Cancer+1 more
University of Michigan Rogel Cancer Center 12
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Not applicableUnknownNCT01189838
What this trial is testing

The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma

Who this might be right for
Carcinoma, Transitional Cell
Far Eastern Memorial Hospital 100
Not applicableUnknownNCT04718948
What this trial is testing

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

Who this might be right for
Urothelial CarcinomaUrinary Bladder CancerUrinary Tract Cancer
University of Florence 500
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT03548688
What this trial is testing

Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:

Who this might be right for
Urothelial Carcinoma
British Urology Researchers in Surgical Training 11,059
Large-scale testing (Phase 3)Not Yet RecruitingNCT05810623
What this trial is testing

Single-Dose Intravesical Chemotherapy After Diagnostic URS

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaBladder Cancer
David D'Andrea 394
Testing effectiveness (Phase 2)UnknownNCT03209206
What this trial is testing

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

Who this might be right for
Urothelial Carcinoma
Seoul National University Hospital 84
Testing effectiveness (Phase 2)Ended earlyNCT01663285
What this trial is testing

Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)

Who this might be right for
Urothelial CancerBladder Cancer
University of Michigan Rogel Cancer Center 1
Next Page